A federal judge ruled on Monday that a $37 billion merger between the health insurance providers Aetna and Humana should not be consummated on antitrust grounds, siding with the Justice Department, which had been seeking to block the deal.
The court “mostly agrees” with the government’s argument that the deal would lessen competition for Medicare Advantage plans and health insurance sold on public exchanges, Judge John D. Bates of the Federal District Court for the District of Columbia said in the ruling.
Judge Bates disagreed with the company’s rebuttal, arguing that regulation would be unable to prevent the combined firm from “raising prices or reducing benefits.” He said that neither new competitors nor divestitures would be enough to attenuate the concentration in the industry from such a deal.
An Aetna spokesman said the company was reviewing the opinion and “is giving serious consideration to an appeal”
The ruling came six months after the Justice Department sued to block the deal, along with a separate one between the health insurance providers Cigna and Anthem.
Another judge, Amy Berman Jackson, has yet to issue a ruling on Cigna and Anthem, a merger that had been seen as the riskier transaction because the two companies have more overlap nationally.
Read Decision HERE
Full Content: New York Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas